Boston Scientific

NYSE: BSX
New York Stock Exchange
Healthcare Medical Devices
Global Rank
#106
Country Rank
#65
Market Cap
157.52 B
Price
106.47
Change (%)
0.60%
Volume
6.35 M

Boston Scientific's latest marketcap:

157.52 B

As of 07/30/2025, Boston Scientific's market capitalization has reached $157.52 B. According to our data, Boston Scientific is the 106th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.

Market Cap 157.52 B
Revenue (ttm) 18.49 B
Net Income (ttm) 2.5 B
Shares Out 1.48 B
EPS (ttm) 1.68
Forward PE 34.25
Ex-Dividend Date n/a
Earnings Date 07/23/2025
Market Cap Chart
Data Updated: 07/30/2025

Boston Scientific's yearly market capitalization.

Boston Scientific has seen its market value grow from $10.53 B to $157.52 B since 1998, representing a total increase of 1,395.29% and an annual compound growth rate (CAGR) of 10.71%.
Date Market Cap($) Change (%) Global Rank
07/30/2025 $157.52 B 18.95% 106
12/31/2024 $131.64 B 55.44% 119
12/29/2023 $84.69 B 27.79% 170
12/30/2022 $66.27 B 9.48% 208
12/31/2021 $60.53 B 17.59% 294
12/31/2020 $51.48 B -18.33% 302
12/31/2019 $63.03 B 28.88% 184
12/31/2018 $48.9 B 43.66% 199
12/29/2017 $34.04 B 15.58% 375
12/30/2016 $29.45 B 18.74% 342

Company Profile

About Boston Scientific Corporation

Boston Scientific Corporation is a global leader in developing, manufacturing, and marketing medical devices for interventional medical specialties. Headquartered in Marlborough, Massachusetts, the company was founded in 1979 and operates through two primary segments: MedSurg and Cardiovascular.

Key Product Offerings

  • MedSurg Segment:
    • Gastrointestinal solutions, including resolution clips, biliary stent systems, and single-use duodenoscopes.
    • Urological devices such as ureteral stents, catheters, and laser systems.
    • Neurological products for chronic pain management, including spinal cord stimulators and deep brain stimulation systems.
  • Cardiovascular Segment:
    • Technologies for coronary artery disease and aortic valve conditions.
    • WATCHMAN FLX, a left atrial appendage closure (LAAC) device.
    • Implantable cardiac devices like defibrillators, pacemakers, and remote monitoring systems.

Additional Specialties

The company also provides solutions for:

  • Peripheral arterial and venous diseases.
  • Diagnosis and treatment of cardiac rhythm disorders.
  • Oncology products for cancer diagnosis and treatment.

Boston Scientific continues to innovate in medical technology, improving patient outcomes across a wide range of conditions.

Frequently Asked Questions

  • What is Boston Scientific's (BSX) current market cap?
    As of 07/30/2025, Boston Scientific (including the parent company, if applicable) has an estimated market capitalization of $157.52 B USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
  • Boston Scientific global market capitalization ranking is approximately 106 as of 07/30/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.

MarketCapWatch.com ranks all listed companies worldwide, providing unique insights into market capitalization across industries. As one of the most comprehensive ranking platforms, it covers companies of all sizes and sectors.

Ranking

Copyright © 2025. All rights reserved

Important Disclaimer: All content provided on this website, including hyperlinked pages, related applications, forums, blogs, social media accounts, and other platforms ("the Site"), is for general informational purposes only and sourced from third-party providers. We make no guarantees regarding the accuracy, completeness, or timeliness of the content.

None of the information presented constitutes financial, legal, or professional advice. Users should conduct their own research, evaluation, and verification before making any decisions. Investing and trading carry significant risks that may lead to substantial losses. Therefore, we strongly recommend consulting a qualified financial advisor before taking any action.